AHR and multiple sclerosis: Furthermore, in an animal model of multiple sclerosis (autoimmune encephalomyelitis), treatment with laquinimod, which crosses the blood–brain barrier, reduces astrogliosis and prevents the production of downstream proinflammatory cytokines in an AhR-dependent manner [251].